Relypsa is a biopharmaceutical company leading the discovery, development and commercialization of polymer-based medicines to treat conditions that are often overlooked and undertreated, but that can have a serious impact on patient lives or even be life-threatening.
Relypsa was founded in October 2007 and is headquartered in Redwood City, Calif. In 2015, we received FDA approval for our first medicine, which was developed based on our polymer technology platform for the treatment of hyperkalemia. In September 2016, Relypsa became a Vifor Pharma company.
Today, we have more than 400 employees united by a passion for improving peopleÍs lives. To learn more about who we are and the work we do, please visit www.relypsa.com.
- Company Name:Relypsa
(View Trends)
-
Headquarters: (View Map)Redwood City, CA, United States
-
Biotechnology
-
500 - 1,000 employees
- 1980584 Global Rank
- 561236 United States
-
Search94.47%
-
Direct5.53%
-
Display0.00%
-
Mail0.00%
-
Referrals0.00%
-
Social0.00%
- United States 89.7%
- India 1.6%
- Canada 1.5%
- Twin Cities
- 0 SDKs
- App Url: https://itunes.apple.com/app/ilypsa-inc-/id1434901182
- App Support: http://www.relypsa.com
- Genre: Medical
- Bundle ID: com.relypsa.kplusknowledgehub
- App Size: 147 M
- Version: 2.7.2.1
- Release Date: October 17th, 2018
- Update Date: October 25th, 2018
Description:
Keep up to date with the latest news on hyperkalemia from Relypsa!
Download the app to:
- Receive monthly updates on select hyperkalemia topics
- Check Relypsa’s national congress schedule and plan your own participation
- Receive invitations to product theatres, and other activities
- Be the first to access exclusive resources as we produce and add new content
